Skip to main content
Clinical Trials/NL-OMON29009
NL-OMON29009
Not yet recruiting
Not Applicable

The use of a Real-Time Medication Monitoring system (RTMM) for the improvement of adherence to inhalation corticosteroids in children with asthma.

Erasmus MC te Rotterdam Evalan BV (manufacturer of RTMM equipment) GlaxoSmythKline (pharmaceutical company)0 sites220 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
asthma, adherence, inhaled corticosteroids, real time medication monitoring (RTMM), sms-reminder
Sponsor
Erasmus MC te Rotterdam Evalan BV (manufacturer of RTMM equipment) GlaxoSmythKline (pharmaceutical company)
Enrollment
220
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Erasmus MC te Rotterdam Evalan BV (manufacturer of RTMM equipment) GlaxoSmythKline (pharmaceutical company)

Eligibility Criteria

Inclusion Criteria

  • 1\. Children younger than 12 years old;
  • 2\. Diagnosed with asthma for at least 6 months;

Exclusion Criteria

  • Refusal to participate in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials